Genetic factors in pancreatitis

Romanian Journal of Gastroenterology

Volumn 14, Issue 1, 2005, Pages 53-61

  Grigorescu, Mircea ^a   Dan Grigorescu, Mircea ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

CFTR; Immune modulating genes; Pancreatitis; PRSS1 mutations; SPINK 1 mutations

Indexed keywords

TRYPSINOGEN;

ACUTE PANCREATITIS; CHRONIC INFLAMMATION; CHRONIC PANCREATITIS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FIBROSIS; GENE INTERACTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INFLAMMATION; MUTATOR GENE; PANCREAS INJURY; PANCREAS SECRETION; PANCREATITIS; PATHOGENESIS; PRSS1 GENE; REVIEW; RISK FACTOR; SPINK1 GENE;

EID: 16244418401     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-759.
2. Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis. Report of the Second International Symposium on the Classification of Pancreatitis. Marseille, France, March 28-30, 1984. Gastroenterology 1985; 89: 683-685.
3. Sarles H, Adler G, Dani R et al. The pancreatitis, classification of Marseille-Rome 1988. Scand J Gastroenterol 1989; 24: 641-642.
4. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification and new genetic developments. Gastroenterology 2001; 120: 682-707.
5. Comfort M, Steinberg A. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952; 21: 54-63.
6. Sossenheimer M, Aston C, Ehrlich G et al. Clinical characteristics of hereditary pancreatitis in a large family based on high-risk haplotype. Am J Gastroenterol 1997; 92: 1113-1116.
7. Le Bodic L, Schnee M, Georgelin T et al. An exceptional genealogy for hereditary chronic pancreatitis. Dig Dis Sci 1996; 41: 1504-1510.
8. Perrault J. Hereditary pancreatitis. Gastroenterol Clin North Am 1994; 23: 743-752.
9. Le Bodic L, Bignon JD, Raguenes O et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet 1996; 5: 549-554.
10. Whitcomb DC, Preston RA, Aston CE et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996; 110: 1975-1980.
11. Grendell JH. Genetic factors in pancreatitis. Curr Gastroenterol Rep 2003; 5: 105-109
12. Scheele G, Bartelt D, Bieger W. Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology 1981; 80: 461-473.
13. Rinderknecht H, Rener IG, Abramson SB, Carmack C. Mesotrypsin: a new inhibitor resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 1984; 86: 681-692.
14. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996; 272: 1755-1762.
15. Pandya A, Blanton SH, Landa B et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics 1996; 38: 227-230.
16. Whitcomb DC. Value of genetic testing in the management of pancreatitis. Gut 2004; 53: 1710-1717.
17. Gaboriaud C, Serre L, Guy Crotte O et al. Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr 151. J Mol Biol 1996; 259: 995-1010.
18. Simon P, Weiss FU, Sahin-Tóth M et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122->Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2001; 21: 21.
19. Sutton R, Criddle D, Raraty MG et al. Signal transduction, calcium and acute pancreatitis. Pancreatology 2003; 3: 497-505.
20. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med 1987; 316: 144-156.
21. nd Ed. New York: Raven Press, 1993: 219-251.
22. Whitcomb DC. Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 46-52.
23. Steer ML, Meldolesi J, Figarella C. Pancreatitis. The role of lysosomes. Dig Dis Sci 1984; 29: 934-938.
24. Greenbaum LM, Hirshkowitz A, Shoichet I. The activation of trypsinogen by cathepsin. J Biol Chem 1959; 234: 2885-2890.
25. Colomb E, Figarella C. Comparative studies on the mechanisms of activation of the two human trypsinogens. Biochem Biophys Acta 1979; 571: 343-351.
26. Whitcomb DC. Hereditary pancreatitis: new insight into acute and chronic pancreatitis. Gut 1994; 45: 317-322.
27. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14; 141-145.
28. Gorry MC, Gabbaizedeh D, Furey W et al. Multiple mutations in the cationic trypsinogen gene are associated with hereditary pancreatitis. Gastroenterology 1997; 113: 1063-1068.
29. Applebaum-Shapiro SE, Finch R, Pfützer RH et al. Hereditary pancreatitis in North America: The Pittsburgh Midwest Multi-Center Pancreatic Study Group. Pancreatology 2001; 1: 439-443.
30. Sahin-Tóth M, Tóth M. Gain-of function mutation associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 2000; 278: 286-289.
31. Teich N, Mössner J, Keim V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mut 1998; 12: 39-43.
32. Nishimori I, Kamakura M, Fujikawa-Abachi K et al. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999; 44: 259-263.
33. Sibert JR. Hereditary pancreatitis in England and Wales. J Med Genet 1978; 15: 189-201.
34. Sweeney JT, Ulrich CD. Genetics of pancreatic disease. Clin Perspect Gastroenterol 2002 march/april: 110-116.
35. Lowenfels A, Maisonneuve P, Di Magno E et al. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997; 89: 442-446.
36. Amann ST, Gates LK, Aston CE et al. Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut 2001; 48: 542-547.
37. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with recurrent acute and chronic pancreatitis. Gastroenterology 1999; 117: 7-10.
38. Férec O, Raguénès O, Salomon R et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999; 36: 228-232.
39. Teich N, Ockenga J, Hoffmeister A et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000; 119: 461-465.
40. Chen JM, Piepoli Bis A, Le Bodic L et al. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet 2001; 59: 189-193.
41. Tautermann G, Ruebsamen H, Beck M et al. R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis. Digestion 2001; 64: 226-232.
42. Teich N, Bauer N, Mössner J. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002; 97: 341-346.
43. Witt H. Chronic pancreatitis and cystic fibrosis. Gut 2003; 52(suppl II): 31-41.
44. Teich N, Le Marechal C, Kukor Z et al. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsinogen (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 2004; 23: 22-31.
45. Keim V, Teich N. Idiopathic vs hereditary pancreatitis. JAMA 2003; 289: 983-984.
46. Teich N, Mösner J, Keim V. Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis? Gut 1999; 44: 413-416.
47. Hassan Z, Mohan V, McDermott MF et al. Pancreatitis fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Rev 2000; 16: 454-457.
48. Rossi L, Withcomb DC, Ehrlich GD et al. Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Pancreas 1998; 17: 278-280.
49. Teich N, Mösner J, Keim V. Systematic overviews of genetic variants of the cationic trypsinogen and SPINK 1 in pancreatitis patients. In: Durie P, Lerch MM, Lowenfels AB et al (eds). Genetic disorders of the exocrine pancreas: an overview and update. Basel: Karger 2002: 20-22.
50. Whitcomb DC. Hereditary diseases of the pancreas. In: Yamada T, Albers DH, Laine L et al (eds). Textbook of gastroenterology. Philadelphia: Lippincott Williams and Wilkins 2003: 2147-2165.
51. Ellis I, Lerch MM, Whitcomb DC et al. Genetic testing for hereditary pancreatitis: Guideliness for indications, councelling, consent and privacy issues. Pancreatology 2001; 1: 401-411.
52. Lowenfels AB, Maisonneuve P, Withcomb DC et al. Cigarette smoking a risk factors for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001; 286: 169-170.
53. Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystaline trypsin inhibitor-anticoagulant protein from the pancreas. J Am Chem Soc 1948; 70: 304-340.
54. Horii A, Kobayashi T, Tomita N et al. Primary structure of human pancreatic secretory trypsinogen inhibitor (PSTI) gene. Biochem Biophys Res Commun 1987; 149: 635-641.
55. Bartelt DC, Shapanka R, Greene U. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys 1977; 179: 189-199.
56. Laskowski M, Wu FC. Temporary inhibition of trypsin. J Biol Chem 1953; 204: 797-805.
57. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the serine protease inhibitor Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25: 213-216.
58. Pfützer RH, Barmada NM, Brunskill APJ et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-623.
59. Drenth JPH, Te Morsche R, Jansen JBMJ. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002; 50: 687-692.
60. Chen JM, Mercier B, Audrézet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic pancreatitis. J Med Genet 2000; 37: 67-69.
61. Kuwata K, Hirota M, Sugita H et al. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis. J Gastroenterol 2001; 36: 612-618.
62. Witt H, Luck W, Becher M et al. Mutation in the SPINK 1 trypsin inhibitor gene, alcohol use and chronic pancreatitis. JAMA 2001; 285: 2716-2717.
63. Schneider A, Susman A, Rossi L et al. SPINK 1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002; 123: 1026-1030.
64. Hassan Z, Mohan V, Ali L et al. SPINK 1 is a susceptibility gene for fibrocalculous pancreactic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002; 71: 964-968.
65. Whitcomb DC. How to think about SPINK and pancreatitis. Am J Gastroenterol 2002; 97: 1085-1088.
66. Pfützer RH, Whitcomb DC. SPINK1 mutations are associated with multiple phenotypes. Pancreatology 2001; 1: 457-460.
67. Felderbauer P, Hoffmann P, Einwachter H et al. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK 1 mutations. BMC Gastroenterol 2003; 3: 34.
68. Zielinski J, Rozmahel R, Bozon D et al. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator CFTR/gene. Genomics 199; 10: 214-228.
69. Riordan JR. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993; 55: 609-630.
70. Sheppard DN; Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999; 79: S23-S45.
71. Welsh M, Smith A. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993; 73: 1251-1254.
72. Wilschanski M, Zielenski J, Markiewicz D et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995; 127: 705-710.
73. Mickle JE, Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am 2000; 84: 597-607.
74. Sharer N, Schwarz M, Malone G et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339: 645-652.
75. Cohn JA, Friedman KJ, Noonc PG et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339: 653-658.
76. Ockenga J, Stuhrmann M, Ballman M et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000; 95: 2061-2067.
77. Zielinski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995; 29: 777-807.
78. Noone P, Zhou Z, Silverman LM et al. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121: 1310-1319.
79. Cohn JA, Bornstein JD, Jowell PS. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clin North Am 2000; 84: 621-631.
80. Andrézet MP, Chen JM, Le Maréchal L et al. Determination of the relative contribution of three genes - the cystic fibrosis transmembrane conductance regulatory gene, the cationic trypsinogen gene and the pancreatic secretory trypsin inhibitory gene - to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002; 10: 100-106.
81. Whitcomb DC. Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatitis conditions: Arguments for motion. Can J Gastroenterol 2003; 17: 47-52.
82. Cohn JA. Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: Arguments against the motion. Can J Gastroenterol 2003; 17: 53-55.
83. Ockenga J, Vogel A, Teich N et al. UDP Glucuronosyltransferase (UGT1A7) gene polymorphysms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003; 124: 1802-1808.
84. Hanck C, Schneider A, Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Best Pract Res Clin Gastroenterol 2003; 17: 613-623.
85. Frenzer A, Butler WJ, Norton ID et al. Polymorphism in alcohol - metabolizing enzymes, glutathion-S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol 2002; 17: 177-182.
86. Maruyama K, Takahashi H, Matsushita S et al. Genotypes of alcohol - metabolizing enzymes in relation to alcoholic chronic pancreatitis in Japan. Alcohol Clin Exp Res 1999; 23 (suppl 4): 85S-91S.
87. Yang B, O'Reilly DA, Demaine AG et al. Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol 2001; 23: 91-97.
88. Verlaan M, Te Morsche RH, Roelafs HM et al. Glutathione S-transferase null genotype afford protection against alcohol induced chronic pancreatitis. Am J Med Genet 2003; 1: 34-39.
89. Mews P, Phillias P, Fahmy R et al. Pancreatic, stellate cell respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 2002; 50: 535-541.
90. Beranek H, Teich N, Witt H et al. Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol 2003; 15: 1223-1227.
91. Schneider A, Barmada MM, Slivka A et al. Analysis of tumour necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10 and interferon-gamma polymorphisms in patients with alcoholic pancreatitis. Alcohol 2004; 32: 19-24.
92. Schneider A, Whitcomb DC. Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract Res Clin Gastroenterol 2002; 16: 347-363.